Rajat Mehndiratta

Rajat Mehndiratta is a Health Care Executive at Eisai Pharmaceuticals India, having joined the company in March 2022, where responsibilities include engaging with neurologists and psychiatrists and covering prominent government and private institutions in Delhi. Notably, Rajat successfully launched Dayvigo, India's first dual orexin receptor antagonist for insomnia management. Prior to this role, Rajat worked as a Business Executive at Intas Pharmaceuticals from July 2019 to March 2022, focusing on marketing initiatives, business development, and event organization to enhance sales and outreach. Rajat began the career as a Trainee Pharmacist at Civil Hospital in 2016, dispensing medicines and managing stock. Educational qualifications include an MBA in Marketing from SVKM's Narsee Monjee Institute of Management Studies, a Bachelor's degree in Pharmacy from PDM College of Pharmacy, and a Diploma in Pharmacy from Baba Mastnath University.